110 related articles for article (PubMed ID: 23086714)
1. Is "black geode" sign a characteristic MRI finding for extracranial schwannomas?
Kato H; Kanematsu M; Ohno T; Nishimoto Y; Oshima K; Hirose Y; Nishibori H
J Magn Reson Imaging; 2013 Apr; 37(4):830-5. PubMed ID: 23086714
[TBL] [Abstract][Full Text] [Related]
2. Major-nerve schwannomas versus intramuscular schwannomas.
Shimose S; Sugita T; Kubo T; Matsuo T; Nobuto H; Tanaka K; Arihiro K; Ochi M
Acta Radiol; 2007 Jul; 48(6):672-7. PubMed ID: 17611877
[TBL] [Abstract][Full Text] [Related]
3. Definition of the target sign and its use for the diagnosis of schwannomas.
Koga H; Matsumoto S; Manabe J; Tanizawa T; Kawaguchi N
Clin Orthop Relat Res; 2007 Nov; 464():224-9. PubMed ID: 17767081
[TBL] [Abstract][Full Text] [Related]
4. Differentiation of soft tissue benign and malignant peripheral nerve sheath tumors with magnetic resonance imaging.
Li CS; Huang GS; Wu HD; Chen WT; Shih LS; Lii JM; Duh SJ; Chen RC; Tu HY; Chan WP
Clin Imaging; 2008; 32(2):121-7. PubMed ID: 18313576
[TBL] [Abstract][Full Text] [Related]
5. Orbital schwannomas: findings from magnetic resonance imaging in 62 cases.
Wang Y; Xiao LH
Eye (Lond); 2008 Aug; 22(8):1034-9. PubMed ID: 17464300
[TBL] [Abstract][Full Text] [Related]
6. Enhanced mass on contrast-enhanced breast MR imaging: Lesion characterization using combination of dynamic contrast-enhanced and diffusion-weighted MR images.
Yabuuchi H; Matsuo Y; Okafuji T; Kamitani T; Soeda H; Setoguchi T; Sakai S; Hatakenaka M; Kubo M; Sadanaga N; Yamamoto H; Honda H
J Magn Reson Imaging; 2008 Nov; 28(5):1157-65. PubMed ID: 18972357
[TBL] [Abstract][Full Text] [Related]
7. Chronic tibiofibular syndesmosis injury of ankle: evaluation with contrast-enhanced fat-suppressed 3D fast spoiled gradient-recalled acquisition in the steady state MR imaging.
Kim S; Huh YM; Song HT; Lee SA; Lee JW; Lee JE; Chung IH; Suh JS
Radiology; 2007 Jan; 242(1):225-35. PubMed ID: 17185669
[TBL] [Abstract][Full Text] [Related]
8. Renal masses: quantitative analysis of enhancement with signal intensity measurements versus qualitative analysis of enhancement with image subtraction for diagnosing malignancy at MR imaging.
Hecht EM; Israel GM; Krinsky GA; Hahn WY; Kim DC; Belitskaya-Levy I; Lee VS
Radiology; 2004 Aug; 232(2):373-8. PubMed ID: 15215544
[TBL] [Abstract][Full Text] [Related]
9. Is gadolinium necessary for MRI follow-up evaluation of cystic lesions in the pancreas? Preliminary results.
Macari M; Lee T; Kim S; Jacobs S; Megibow AJ; Hajdu C; Babb J
AJR Am J Roentgenol; 2009 Jan; 192(1):159-64. PubMed ID: 19098196
[TBL] [Abstract][Full Text] [Related]
10. Gadoxetic acid-enhanced magnetic resonance imaging for differentiating small hepatocellular carcinomas (< or =2 cm in diameter) from arterial enhancing pseudolesions: special emphasis on hepatobiliary phase imaging.
Sun HY; Lee JM; Shin CI; Lee DH; Moon SK; Kim KW; Han JK; Choi BI
Invest Radiol; 2010 Feb; 45(2):96-103. PubMed ID: 20057319
[TBL] [Abstract][Full Text] [Related]
11. Serial MR imaging of small arterially-enhancing liver lesions in patients with chronic liver disease.
Korpraphong P; Leyendecker JR; Hildebolt CF; Narra V; Bae KT; Brown JJ
J Med Assoc Thai; 2009 Apr; 92(4):548-55. PubMed ID: 19374308
[TBL] [Abstract][Full Text] [Related]
12. "Flow-void" sign at MR imaging: a rare finding of extracranial head and neck schwannomas.
Kato H; Kanematsu M; Mizuta K; Aoki M; Kuze B; Ohno T; Oshima K; Hirose Y
J Magn Reson Imaging; 2010 Mar; 31(3):703-5. PubMed ID: 20187216
[TBL] [Abstract][Full Text] [Related]
13. MRI features in the differentiation of malignant peripheral nerve sheath tumors and neurofibromas.
Wasa J; Nishida Y; Tsukushi S; Shido Y; Sugiura H; Nakashima H; Ishiguro N
AJR Am J Roentgenol; 2010 Jun; 194(6):1568-74. PubMed ID: 20489098
[TBL] [Abstract][Full Text] [Related]
14. Small hyperintense hepatic lesions on T1-weighted images in patients with cirrhosis: evaluation with serial MRI and imaging features for clinical benignity.
Shimizu A; Ito K; Sasaki K; Hayashida M; Tanabe M; Shimizu K; Matsunaga N
Magn Reson Imaging; 2007 Dec; 25(10):1430-6. PubMed ID: 17524587
[TBL] [Abstract][Full Text] [Related]
15. Hepatocellular carcinoma in North America: a multiinstitutional study of appearance on T1-weighted, T2-weighted, and serial gadolinium-enhanced gradient-echo images.
Kelekis NL; Semelka RC; Worawattanakul S; de Lange EE; Ascher SM; Ahn IO; Reinhold C; Remer EM; Brown JJ; Bis KG; Woosley JT; Mitchell DG
AJR Am J Roentgenol; 1998 Apr; 170(4):1005-13. PubMed ID: 9530051
[TBL] [Abstract][Full Text] [Related]
16. Malignant spiculated breast masses: dynamic contrast enhanced MR (DCE-MR) imaging enhancement characteristics and histopathological correlation.
Gokalp G; Topal U; Yildirim N; Tolunay S
Eur J Radiol; 2012 Feb; 81(2):203-8. PubMed ID: 21236612
[TBL] [Abstract][Full Text] [Related]
17. Enhancement of the liver and pancreas in the hepatic arterial dominant phase: comparison of hepatocyte-specific MRI contrast agents, gadoxetic acid and gadobenate dimeglumine, on 3 and 1.5 Tesla MRI in the same patient.
Kim HJ; Kim BS; Kim MJ; Kim SH; de Campos RO; Hernandes M; Semelka RC
J Magn Reson Imaging; 2013 Apr; 37(4):903-8. PubMed ID: 23065959
[TBL] [Abstract][Full Text] [Related]
18. Intrahepatic mass-forming cholangiocarcinoma: enhancement patterns on gadoxetic acid-enhanced MR images.
Kang Y; Lee JM; Kim SH; Han JK; Choi BI
Radiology; 2012 Sep; 264(3):751-60. PubMed ID: 22798225
[TBL] [Abstract][Full Text] [Related]
19. T2-weighted MR imaging in the assessment of cirrhotic liver.
Hussain HK; Syed I; Nghiem HV; Johnson TD; Carlos RC; Weadock WJ; Francis IR
Radiology; 2004 Mar; 230(3):637-44. PubMed ID: 14739306
[TBL] [Abstract][Full Text] [Related]
20. MRI of fat necrosis of the breast: the "black hole" sign at short tau inversion recovery.
Trimboli RM; Carbonaro LA; Cartia F; Di Leo G; Sardanelli F
Eur J Radiol; 2012 Apr; 81(4):e573-9. PubMed ID: 21742453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
